Sign Up to like & get
recommendations!
1
Published in 2022 at "Drug Metabolism and Disposition"
DOI: 10.1124/dmd.121.000668
Abstract: Lurbinectedin is a novel and potent selective inhibitor of active transcription of protein-coding genes, triggering apoptosis of cancerous cells. It has been approved for the treatment of patients with metastatic small-cell lung cancer with disease…
read more here.
Keywords:
inhibitor active;
transcription protein;
active transcription;
selective inhibitor ... See more keywords